{"corpus_id":52078957,"paper_sha":"36bcf223c8bbd1c2ec3da96edcba1caf63dedab8","doi":"10.1002/jcsm.12337","arxiv_id":null,"pmid":30144305,"pmcid":"6204584","mag_id":2888610531,"dblp_id":null,"acl_id":null,"title":"Impact of different palliative systemic treatments on skeletal muscle mass in metastatic colorectal cancer patients","year":2018,"publication_date":"2018-08-24","venue":"Journal of Cachexia, Sarcopenia and Muscle","journal":{"name":"Journal of Cachexia, Sarcopenia and Muscle","pages":"909 - 919","volume":"9"},"journal_issn":null,"journal_title":null,"publication_types":["JournalArticle"],"pubmed_pub_types":["Journal Article","Research Support, Non-U.S. Gov't"],"s2_fields_of_study":["Medicine"],"reference_count":40,"citation_count":51,"influential_citation_count":0,"is_open_access":true,"arxiv_categories":null,"arxiv_license":null,"arxiv_journal_ref":null,"mesh_headings":[{"d":"Aged","mj":false,"ui":"D000368"},{"d":"Aged, 80 and over","mj":false,"ui":"D000369"},{"d":"Antineoplastic Combined Chemotherapy Protocols","mj":false,"qs":[{"q":"adverse effects","mj":false,"ui":"Q000009"},{"q":"therapeutic use","mj":false,"ui":"Q000627"}],"ui":"D000971"},{"d":"Body Weights and Measures","mj":false,"ui":"D001837"},{"d":"Colorectal Neoplasms","mj":false,"qs":[{"q":"metabolism","mj":true,"ui":"Q000378"},{"q":"pathology","mj":true,"ui":"Q000473"},{"q":"therapy","mj":false,"ui":"Q000628"}],"ui":"D015179"},{"d":"Female","mj":false,"ui":"D005260"},{"d":"Humans","mj":false,"ui":"D006801"},{"d":"Male","mj":false,"ui":"D008297"},{"d":"Middle Aged","mj":false,"ui":"D008875"},{"d":"Muscle, Skeletal","mj":false,"qs":[{"q":"diagnostic imaging","mj":false,"ui":"Q000000981"},{"q":"pathology","mj":true,"ui":"Q000473"}],"ui":"D018482"},{"d":"Neoplasm Metastasis","mj":false,"ui":"D009362"},{"d":"Neoplasm Staging","mj":false,"ui":"D009367"},{"d":"Organ Size","mj":false,"ui":"D009929"},{"d":"Palliative Care","mj":false,"qs":[{"q":"methods","mj":false,"ui":"Q000379"}],"ui":"D010166"},{"d":"Tomography, X-Ray Computed","mj":false,"ui":"D014057"}],"chemicals":null,"comments_corrections":null,"source_flags":5,"s2_open_access_pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jcsm.12337","s2_open_access_landing_url":"https://www.semanticscholar.org/paper/36bcf223c8bbd1c2ec3da96edcba1caf63dedab8","s2_open_access_license":"CCBYNC","s2_open_access_status":"GOLD","pmc_open_access_pdf_url":null,"pmc_open_access_landing_url":null,"pmc_open_access_license":null,"pmc_open_access_status":null,"unpaywall_open_access_pdf_url":null,"unpaywall_open_access_landing_url":null,"unpaywall_open_access_license":null,"unpaywall_open_access_status":null,"abstract":"Observational studies suggest that loss of skeletal muscle mass (SMM) is associated with chemotherapy‐related toxicity, poor quality of life, and poor survival in metastatic colorectal cancer (mCRC) patients. Little is known about the evolution of SMM during palliative systemic therapy. We investigated changes in SMM during various consecutive palliative systemic treatment regimens using repeated abdominal computed tomography scans of mCRC patients who participated in the randomized phase 3 CAIRO3 study.","claims":[{"public_id":"cl_0e83a8cd71875a90ad6d679a86fb6e90","status":"active","text":"Repeated abdominal computed tomography scans were used to investigate changes in skeletal muscle mass during consecutive palliative systemic treatment regimens in metastatic colorectal cancer patients enrolled in the randomized phase 3 CAIRO3 study.","confidence":0.98,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_0e83a8cd71875a90ad6d679a86fb6e90"}],"concepts":[{"public_id":"co_1187401b2d6b0f9ddfa0ca8a2c4f6a39","status":"active","name":"skeletal muscle mass","description":"The amount of muscle tissue in the body, assessed here as a longitudinal outcome in metastatic colorectal cancer patients.","types":["outcome","biomarker"],"aliases":["SMM"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_1187401b2d6b0f9ddfa0ca8a2c4f6a39"},{"public_id":"co_1cdc698c5c54cbde22b9ef82981600fb","status":"active","name":"randomized phase 3 CAIRO3 study","description":"A randomized phase 3 clinical study providing the patient cohort for the analysis.","types":["clinical trial"],"aliases":["CAIRO3 study"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_1cdc698c5c54cbde22b9ef82981600fb"},{"public_id":"co_336ffe630a712316ccfd57b5e0fae6ce","status":"active","name":"abdominal computed tomography scans","description":"Cross-sectional imaging of the abdomen used here to measure skeletal muscle mass over time.","types":["imaging method"],"aliases":["abdominal CT scans","CT scans"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_336ffe630a712316ccfd57b5e0fae6ce"},{"public_id":"co_99e2d833df580f907207c5cd1b021cfe","status":"active","name":"palliative systemic treatment regimens","description":"Consecutive systemic therapy regimens given with palliative intent for metastatic colorectal cancer.","types":["treatment"],"aliases":["systemic therapy regimens"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_99e2d833df580f907207c5cd1b021cfe"},{"public_id":"co_fd02364bfa2e59b2b683366f786db7a4","status":"active","name":"metastatic colorectal cancer patients","description":"Patients with colorectal cancer that has spread to distant sites.","types":["patient population","condition"],"aliases":["mCRC patients","mCRC"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_fd02364bfa2e59b2b683366f786db7a4"}],"external_ids":{"DOI":"10.1002/jcsm.12337","ArXiv":null,"PubMed":30144305,"PubMedCentral":"6204584","MAG":2888610531,"DBLP":null,"ACL":null},"open_access":{"is_open_access":true,"pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jcsm.12337","landing_url":"https://www.semanticscholar.org/paper/36bcf223c8bbd1c2ec3da96edcba1caf63dedab8","source":"semantic_scholar","pdf_url_source":"semantic_scholar_open_access_pdf","license":"CCBYNC","status":"GOLD","reason":null},"reference_availability":{"status":"available","references_indexed":true,"full_text_available":false,"full_text_source":null,"count_basis":"semantic_scholar_metadata","extraction_status":"not_applicable","reason":null},"source":{"provider":"episteme2","base_corpus":"semantic_scholar_dump","freshness_mode":"unknown","basis":["semantic_scholar_metadata","postgres_metadata"],"limits":["paper metadata is based on indexed upstream scholarly datasets","claims and concepts are available only for extracted papers","absence of claims or concepts means no extracted graph data is available in this response"],"status":"available","degraded":false,"degraded_reasons":[],"diagnostics":{"status":"available","degraded":false,"degraded_reasons":[],"metadata_status":"available","graph_status":"available","abstract_status":"available"},"source_flags":5},"paper_id":631006,"paper_uid":"0c3f80ec-141e-4966-a324-c9ecfe6e43d2","canonical_identity":{"paper_id":631006,"paper_uid":"0c3f80ec-141e-4966-a324-c9ecfe6e43d2","identity_status":"available","lookup_basis":"semantic_scholar_external_id","compatibility_path":"corpus_id"},"url":"https://sah.borca.ai/papers/52078957"}